Pages that link to "Q42382222"

The following pages link to Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice (Q42382222):

Displaying 23 items.

• Current prospects and challenges for epilepsy gene therapy (Q27002627) (← links)
• Gene therapy in epilepsy (Q33960096) (← links)
• Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration (Q34261645) (← links)
• Gene therapy for epilepsy. (Q34375803) (← links)
• Single-cell bioelectrical impedance platform for monitoring cellular response to drug treatment (Q35228555) (← links)
• Valproic acid induces neuronal cell death through a novel calpain-dependent necroptosis pathway (Q35371452) (← links)
• The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity. (Q36015078) (← links)
• Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells (Q36717205) (← links)
• Strategies for intranasal delivery of therapeutics for the prevention and treatment of neuroAIDS. (Q37015506) (← links)
• The herpes simplex virus type 2 gene ICP10PK protects from apoptosis caused by nerve growth factor deprivation through inhibition of caspase-3 activation and XIAP up-regulation (Q37098658) (← links)
• The growth compromised HSV-2 mutant DeltaRR prevents kainic acid-induced apoptosis and loss of function in organotypic hippocampal cultures (Q37110420) (← links)
• Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine (Q37207631) (← links)
• Cell and gene therapies for refractory epilepsy. (Q37211817) (← links)
• Intranasal delivery of therapeutic proteins for neurological diseases. (Q37880893) (← links)
• Progress in gene therapy for neurological disorders. (Q38100997) (← links)
• Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier (Q38569775) (← links)
• Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to ΔPK oncolytic activity in melanoma (Q38615069) (← links)
• Gene transfer to the outflow tract. (Q38821882) (← links)
• The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins. (Q39792514) (← links)
• DeltaRR vaccination protects from KA-induced seizures and neuronal loss through ICP10PK-mediated modulation of the neuronal-microglial axis (Q41894500) (← links)
• Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain. (Q42228954) (← links)
• ICP10PK inhibits calpain-dependent release of apoptosis-inducing factor and programmed cell death in response to the toxin MPP+. (Q42565249) (← links)
• Gene therapy for epilepsy (Q85070131) (← links)